Samuel D. Riccitelli - 28 Feb 2022 Form 4 Insider Report for BIOCEPT INC

Role
Interim President and CEO, Director
Signature
/s/ Samuel D. Riccitelli
Issuer symbol
N/A
Transactions as of
28 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Mar 2022, 19:19:28 UTC
Previous filing
20 Jul 2021
Next filing
03 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Stock Option (right to buy) Award $0 +250,000 $0.000000 250,000 28 Feb 2022 Common Stock 250,000 $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable in 48 equal monthly installments from the vesting commencement date of February 28, 2022.